Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
about
Carrageenan is a potent inhibitor of papillomavirus infectionCould human papillomaviruses be spread through blood?Prophylactic human papillomavirus vaccinesThe role of HPV in head and neck cancer and review of the HPV vaccineInfectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirusPrevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, IndiaPersistent infection with high-risk human papilloma viruses: cohort study, Mérida, VenezuelaPapillomavirus Infectious Pathways: A Comparison of SystemsEarly Defensive Mechanisms against Human Papillomavirus InfectionMaturation of the Human Papillomavirus 16 CapsidThe combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinomaDifferential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV typesHuman papillomavirus persistence in young unscreened women, a prospective cohort studyHuman papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis.Prognostic value of histopathology and trends in cervical cancer: a SEER population studyA methodological framework to distinguish spectrum effects from spectrum biases and to assess diagnostic and screening test accuracy for patient populations: application to the Papanicolaou cervical cancer smear test.Seroprevalence of 34 human papillomavirus types in the German general population.Correlates of cervicovaginal human papillomavirus detection in perimenopausal women.Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancerDifferences in age-specific HPV prevalence between self-collected and health personnel collected specimen in a cross-sectional study in Ghana.Evaluation and Management of Anal Intraepithelial Neoplasia in HIV-Negative and HIV-Positive Men Who Have Sex with MenPersistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysisReversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors.An armamentarium of wart treatmentsCanadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysisPolicy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage Study.Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.The Anyang Esophageal Cancer Cohort Study: study design, implementation of fieldwork, and use of computer-aided survey system.EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activationHuman alpha-defensins block papillomavirus infectionHPV vaccine: an overview of immune response, clinical protection, and new approaches for the future.Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix.HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico.Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.Infection and cervical neoplasia: facts and fiction.Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from BrazilPredictors of three dose on-time compliance with HPV4 vaccination in a disadvantaged, underserved, safety net population in the US Midwest.Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.Long-term follow-up observation of the safety, immunogenicity, and effectiveness of Gardasil™ in adult womenEnd-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.
P2860
Q21089628-A9172CC8-601E-4CD7-A734-BEC72B2541A8Q24538854-8A7D71B0-BC92-4A9D-920A-9572EF81C58CQ24545449-79E32F12-3DA8-444E-9357-CB9A0E7CD216Q24630128-54FA5D07-7E10-488F-B827-9C652AFA8796Q24651563-DFA60C67-BB9C-4228-B84D-08822D22B924Q25257293-7BA415A5-9527-42D7-8094-AA586A154CF5Q26777706-37DBADD8-48B3-4019-B9F6-C6DED9395D7CQ26801497-2CA11410-ABE6-46E1-940D-C5556C9FE66FQ26852611-477F6C74-E981-4003-A39E-8BAFC2FC0DF7Q27684947-72867754-B718-4353-BF4B-44C820721454Q28387851-D594D3E2-F9ED-4F7F-9009-40A03F4C5D9CQ28534531-8CA31979-8D3C-4B96-8F66-1B743E2D6A16Q28742332-7FD20074-98B9-47B0-81D3-015378B250E1Q30878077-26FAC74B-ECC3-4133-AF5C-33FEDA8F47C2Q33295075-DF041344-48AA-41D7-9ECC-2A1B2E2F5E1BQ33320771-EF66051B-8085-4EE1-B9D9-383B1D454F21Q33345224-73CEBA76-6892-4272-ACB3-EA17B5B3E0AEQ33675027-6A29661C-B560-4834-8934-F1D6ACA420C3Q33699084-9EC4EC42-31F6-43A5-8D35-D933E61EBDF1Q33706242-5DD12AA6-50D7-42F0-BAF3-9FE5927F37D4Q33814136-A0B21EB9-8DF2-4578-B6CD-443845643553Q33883532-237A0D76-1F3D-4B34-88A6-37B3149A5B4FQ33940220-6EFAD669-4D64-47C4-8385-BB1D1D087515Q34001838-15B67B3D-8C39-4F3A-BA21-890F1F5A82BEQ34011249-2E2AC637-5BA8-4282-BBD2-9D8B65B9833BQ34093282-1B40E7F2-2AD3-4103-9328-1C7FB03865A6Q34121746-14580D52-E328-4F38-81FA-B61130B20F72Q34157332-6418C98A-840B-4F6F-86B2-65DA7120A8B6Q34326712-2CAAE189-E5AB-4EF9-90D0-D468100E061DQ34334899-D60F7E7F-EBC2-4194-B7C2-4523235EE44AQ34335370-5D5DE25D-1712-44D4-A938-61C8D2335F9BQ34346085-9AE62071-91FB-4FEF-88C1-E0214786FCD1Q34511387-9F584CB1-770B-4070-B2A5-8E16483106B2Q34604698-38FD0891-7B95-4250-9F6C-7AD5453DBBFCQ34843163-A1C97D1F-021E-4DF1-801C-CDBB9CD2FDF0Q34863458-9BF7FB4D-64C9-4029-A25B-C3AE33EDE470Q34949073-0258B1FD-8F8F-47DB-8B2E-C8386D9AA536Q35055665-6D20C79B-9DB9-4156-BFB3-635D9D07665CQ35082473-D0024001-4045-4773-B741-2C2E97B065DBQ35108338-95919090-C4C8-484E-95E3-77E29665A277
P2860
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
@ast
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
@en
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
@nl
type
label
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
@ast
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
@en
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
@nl
prefLabel
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
@ast
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
@en
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
@nl
P1476
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia
@en
P2093
Mark Schiffman
P356
10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003476
P577
2003-01-01T00:00:00Z